Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | LIMK1 | P53667 | 3/20 | 0.33 |
| ▸ | IKBKB | O14920 | 1/20 | 0.33 |
| ▸ | CHUK | O15111 | 1/20 | 0.33 |
| ▸ | CDC7 | O00311 | 1/20 | 0.33 |
| ▸ | CLK1 | P49759 | 1/20 | 0.33 |
| ▸ | DBF4 | Q9UBU7 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19721362 | 0.81 | HPGD (0.36) | HPGDLIMK1IKBKBCHUKCDC7 | |
| SCHEMBL21315919 | 0.72 | LIMK1 (0.35) | HPGDLIMK1IKBKBCHUKCDC7 | |
| SCHEMBL19721360 | 0.69 | HPGD (0.36) | HPGDLIMK1IKBKBCHUKCDC7 | |
| SCHEMBL26276546 | 0.69 | KDM4E (0.35) | — | |
| SCHEMBL22683579 | 0.64 | CA12 (0.35) | LMNATSHR | |
| SCHEMBL4903332 | 0.64 | LIMK1 (0.50) | HPGDLIMK1IKBKBCHUKCDC7 | |
| SCHEMBL21315923 | 0.63 | — | — | |
| SCHEMBL13029609 | 0.59 | NPC1 (0.48) | HPGDLIMK1IKBKBCHUKCDC7 | |
| SCHEMBL30059934 | 0.59 | NPC1 (0.48) | HPGDLIMK1IKBKBCHUKCDC7 | |
| SCHEMBL19299443 | 0.57 | GPR3 (0.40) | HPGDLMNARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11744151-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11744151-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, JUND | HPGD 832/4885LIMK1 1839/4885IKBKB 4445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.